Perfil contemporâneo da intervenção coronária percutânea em octogenários

Freitas, Rafaela Andrade Penalva; Tanajura, Luiz Fernando Leite; Coelho, Nancy Toledo; Centemero, Marinella Patrizia; Chaves, Aurea Jacob; Abizaid, Andrea Claudia Leão Sousa; Silva, Ana Cristina de Seixas; Costa Junior, José de Ribamar; Sousa, Amanda Guerra de Moraes Rego; Sousa, José Eduardo Moraes Rego.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 28(2 Supl): 215-218, 2018.
Artigo Inglês, Português | LILACS | ID: biblio-909690

Documentos relacionados

  1. Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease.
  2. In-hospital Bleeding Outcomes of Oral Anticoagulant and Dual Antiplatelet Therapy During Percutaneous Coronary Intervention: An Analysis From the Japanese Nationwide Registry.
  3. Stroke Outcomes in the COMPASS Trial.
  4. Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies.
  5. Mortality and pre-hospitalization use of low-dose aspirin in COVID-19 patients with coronary artery disease.
  6. Capitalizing on Insights from Human Genetics to Identify Novel Therapeutic Targets for Coronary Artery Disease.
  7. [Association of ITGB3, P2RY12, and CYP2C19 gene polymorphisms with platelet functional activity in patients with coronary heart disease during dual antiplatelet therapy].
  8. Antithrombotic Therapy for Atherosclerotic Cardiovascular Disease Risk Mitigation in Patients With Coronary Artery Disease and Diabetes Mellitus.
  9. Adverse clinical outcomes associated with a low dose and a high dose of aspirin following percutaneous coronary intervention: a systematic review and meta-analysis.
  10. The efficacy and safety of rivaroxaban in coronary artery disease patients with heart failure and sinus rhythm: a systematic review and meta-analysis.